FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
FURX was delisted on the 1st of July, 2014.
1 hedge funds and large institutions have $185K invested in FURIEX PHARMACEUTICALS INC COM STK (DE) in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
88% less capital invested
Capital invested by funds: $1.61M → $185K (-$1.42M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KAM
Krensavage Asset Management
New York
|
-$1.42M |
FURX Hedge Fund Activity: Q4 2015 in Review
1 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) for Q4 2015, worth a combined $185K — down 88% from $1.61M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of FURX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Krensavage Asset Management, exiting entirely with an estimated $1.42M sold.
- 1 institutional investor held FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) as of Q4 2015, down from 2 in Q3 2015.
- Funds reported $185K of FURIEX PHARMACEUTICALS INC COM STK (DE) stock for Q4 2015, down 88% quarter-over-quarter.
- 0 funds opened new FURIEX PHARMACEUTICALS INC COM STK (DE) positions in Q4 2015 and 1 closed out, a net change of -1 holder.
- The largest FURIEX PHARMACEUTICALS INC COM STK (DE) seller in Q4 2015 was Krensavage Asset Management, an estimated $1.42M sold.
Based on aggregated 13F filings for Q4 2015.